Survey on MASLD management by Chinese doctors
Part of Digestive system clinical trials.
This study surveys doctors in China about how they manage Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD), a type of fatty liver disease. It aims to understand current practices and improve patient care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a doctor with a valid medical license.
- You work in a Grade IIIA hospital (a top-level hospital in China).
- Your department is Endocrinology, Hepatology, Infection, or Gastroenterology.
- You are an associate chief physician or higher, or a senior attending physician with at least 3 years experience.
- You see at least 20 patients with MASLD per month (if in Endocrinology) or 30 patients (if in Hepatology, Gastroenterology, or Infectious Diseases).
- You are based in a provincial capital or municipality in China.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is building a model to better predict how metabolic liver disease (MASLD) that has led to cirrhosis (scarring of the liver) will progress. If you have compensated cirrhosis (your liver is still working well) and have been diagnosed with MASLD or a related condition, this research could help develop more personalized care.
This study looks at whether the natural chemicals made by your gut bacteria from the food you eat could affect liver fat and health. If you have MASLD (a fatty liver condition), researchers want to measure these gut-produced substances to better understand the disease.
This study tests whether a traditional Chinese herbal medicine (CXD) combined with a restrictive ketogenic diet can reduce fat buildup in the liver. You may be a good fit if you have fatty liver disease and are interested in trying this combination approach.
This study looks at factors that predict liver cancer and the need for a liver transplant in people with a liver condition called MASLD (metabolic dysfunction-associated steatotic liver disease). The goal is to better understand the disease and improve care.
This study looks at how common obesity is in people with a type of fatty liver disease called MASLD. If you have fatty liver and are overweight, this trial may help doctors understand the link between the two conditions.
This study uses routine blood tests to find people with advanced liver scarring caused by a condition called MASLD. If you are between 50 and 75, have certain metabolic risks, and get blood work from your primary care doctor at select centers, you may be eligible.
Hear when a new Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.